07:50 EDT Jade Biosciences (JBIO) up 16.5% at $10.65 after JADE201 announcement
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JBIO:
- Jade Biosciences Secures $135 Million in Private Placement
- Jade Biosciences prices 13.4M shares at $9.14 in private placement
- Jade Biosciences announces JADE201 afucosylated monoclonal antibody
- Jade Biosciences’ Chief Medical Officer Departs
- Jade Biosciences announces first cohort dosed in Phase 1 trial of JADE101